Transcatheter Embolization and Occlusion Devices | Market Insights | US | 2025
The US TEO device market is expected to grow moderately through 2033, with trends differing across various device segments. Key factors contributing to this growth include the approval of new and innovative devices supported by strong clinical evidence, the expansion of treatment indications through new approvals, and favorable changes to reimbursement policies and clinical guidelines that encourage increased use of these devices.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for TEO devices in the US from 2019 through 2033.
Related Medtech Insights Reports
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Latin America (Supplemental) | 2023
Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate…
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific TEO device market will experience moderate growth through 2033. This growth will be driven by the introduction and rising adoption of new devices supported by favorable clinical…
